Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

141 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The use of cannabidiol for seizure management in patients with brain tumor-related epilepsy.
Warren PP, Bebin EM, Nabors LB, Szaflarski JP. Warren PP, et al. Among authors: nabors lb. Neurocase. 2017 Oct-Dec;23(5-6):287-291. doi: 10.1080/13554794.2017.1391294. Epub 2017 Oct 24. Neurocase. 2017. PMID: 29063814
Assessment of brain tumor angiogenesis inhibitors using perfusion magnetic resonance imaging: quality and analysis results of a phase I trial.
Akella NS, Twieg DB, Mikkelsen T, Hochberg FH, Grossman S, Cloud GA, Nabors LB. Akella NS, et al. Among authors: nabors lb. J Magn Reson Imaging. 2004 Dec;20(6):913-22. doi: 10.1002/jmri.20202. J Magn Reson Imaging. 2004. PMID: 15558578 Clinical Trial.
Phase Ib trial of mutant herpes simplex virus G207 inoculated pre-and post-tumor resection for recurrent GBM.
Markert JM, Liechty PG, Wang W, Gaston S, Braz E, Karrasch M, Nabors LB, Markiewicz M, Lakeman AD, Palmer CA, Parker JN, Whitley RJ, Gillespie GY. Markert JM, et al. Among authors: nabors lb. Mol Ther. 2009 Jan;17(1):199-207. doi: 10.1038/mt.2008.228. Epub 2008 Oct 28. Mol Ther. 2009. PMID: 18957964 Free PMC article. Clinical Trial.
Distress and quality of life in primary high-grade brain tumor patients.
Kvale EA, Murthy R, Taylor R, Lee JY, Nabors LB. Kvale EA, et al. Among authors: nabors lb. Support Care Cancer. 2009 Jul;17(7):793-9. doi: 10.1007/s00520-008-0551-9. Epub 2009 May 7. Support Care Cancer. 2009. PMID: 19421789
Isolated central nervous system posttransplant lymphoproliferative disorder treated with high-dose intravenous methotrexate.
Nabors LB, Palmer CA, Julian BA, Przekwas AM, Kew CE. Nabors LB, et al. Am J Transplant. 2009 May;9(5):1243-8. doi: 10.1111/j.1600-6143.2009.02598.x. Am J Transplant. 2009. PMID: 19422350
Medical decision-making capacity in patients with malignant glioma.
Triebel KL, Martin RC, Nabors LB, Marson DC. Triebel KL, et al. Among authors: nabors lb. Neurology. 2009 Dec 15;73(24):2086-92. doi: 10.1212/WNL.0b013e3181c67bce. Neurology. 2009. PMID: 20018637 Free PMC article.
A phase 1 trial of ABT-510 concurrent with standard chemoradiation for patients with newly diagnosed glioblastoma.
Nabors LB, Fiveash JB, Markert JM, Kekan MS, Gillespie GY, Huang Z, Johnson MJ, Meleth S, Kuo H, Gladson CL, Fathallah-Shaykh HM. Nabors LB, et al. Arch Neurol. 2010 Mar;67(3):313-9. doi: 10.1001/archneurol.2010.16. Arch Neurol. 2010. PMID: 20212229 Free PMC article. Clinical Trial.
Patterns of failure for glioblastoma multiforme following concurrent radiation and temozolomide.
Dobelbower MC, Burnett Iii OL, Nordal RA, Nabors LB, Markert JM, Hyatt MD, Fiveash JB. Dobelbower MC, et al. Among authors: nabors lb. J Med Imaging Radiat Oncol. 2011 Feb;55(1):77-81. doi: 10.1111/j.1754-9485.2010.02232.x. J Med Imaging Radiat Oncol. 2011. PMID: 21382192 Clinical Trial.
The RNA-binding protein HuR promotes glioma growth and treatment resistance.
Filippova N, Yang X, Wang Y, Gillespie GY, Langford C, King PH, Wheeler C, Nabors LB. Filippova N, et al. Among authors: nabors lb. Mol Cancer Res. 2011 May;9(5):648-59. doi: 10.1158/1541-7786.MCR-10-0325. Epub 2011 Apr 15. Mol Cancer Res. 2011. PMID: 21498545 Free PMC article.
Phase I trial of sorafenib in patients with recurrent or progressive malignant glioma.
Nabors LB, Supko JG, Rosenfeld M, Chamberlain M, Phuphanich S, Batchelor T, Desideri S, Ye X, Wright J, Gujar S, Grossman SA; New Approaches to Brain Tumor Therapy (NABTT) CNS Consortium. Nabors LB, et al. Neuro Oncol. 2011 Dec;13(12):1324-30. doi: 10.1093/neuonc/nor145. Epub 2011 Sep 27. Neuro Oncol. 2011. PMID: 21954442 Free PMC article. Clinical Trial.
141 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback